Cross-reactive microbial peptides can modulate HIV-specific CD8.sup.+ T cell responses

Heterologous immunity is an important aspect of the adaptive immune response. We hypothesized that this process could modulate the HIV-1-specific CD8.sup.+ T cell response, which has been shown to play an important role in HIV-1 immunity and control. We found that stimulation of peripheral blood mononuclear cells (PBMCs) from HIV-1-positive subjects with microbial peptides that were cross-reactive with immunodominant HIV-1 epitopes resulted in dramatic expansion of HIV-1-specific CD8.sup.+ T cells. Interestingly, the TCR repertoire of HIV-1-specific CD8.sup.+ T cells generated by ex vivo stimulation of PBMCs using HIV-1 peptide was different from that of cells stimulated with cross-reactive microbial peptides in some HIV-1-positive subjects. Despite these differences, CD8.sup.+ T cells stimulated with either HIV-1 or cross-reactive peptides effectively suppressed HIV-1 replication in autologous CD4.sup.+ T cells. These data suggest that exposure to cross-reactive microbial antigens can modulate HIV-1-specific immunity.